Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Shionogi & Co. Ltd.

Third Time Lucky As Japan Finally Approves Shionogi’s Oral COVID Antiviral

Shionogi’s once-daily oral COVID-19 antiviral finally gets Japan approval after being considered for the third time by an expert panel, paving the way for public availability of the country’s first such home-grown option in early December.

Japan Commercial

Asia Deal Watch: Eisai Advances Portfolio Focus With Divestiture Of Two Products To DKSH

Plus deals involving Dong-A/Polifarma, Intas/Syna, Kissei/Synmosa, Ono/Memo, Takeda/Shionogi, Fosun/Lilly and JW Therapeutics/2seventy bio.

Deal Watch Business Strategies

Japan Q2 Roundup: Mixed Bag For Majors But Forex Provides Boost

Japan's top pharma firms logged generally strong performances for mainstay global drugs in the fiscal period ended 30 September, with the weakened yen adding substantially to figures for those with large overseas sales. Astellas and Eisai are among those awaiting important global-first approvals for potential blockbusters.

Japan Strategy

Deal Watch: OrsoBio Reveals Its Metabolic Health Focus With Four Licensing Pacts

California biotech also notes prior licensing deal with Gilead for mitochondrial candidate. Twentyeight-Seven acquires RNA-splicing cancer candidate from Basilea.

Deal Watch Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • OTC, Consumer
  • Biotechnology
    • Drug Discovery Tools
  • Other Names / Subsidiaries
    • Shionogi Healthcare Co., Ltd
    • Shionogi Pharma Co., Ltd
    • Shionogi Techno Advance Research Co., Ltd.
    • Shionogi Administration Service Co., Ltd.
    • Shionogi Business Partner Co., Ltd
    • Shionogi Marketing Solutions Co., Ltd
    • Shionogi Career Development Center Co., Ltd.
    • Shionogi Digital Science Co., Ltd.
    • Shionogi Pharmacovigilance Center Co., Ltd.
    • Aburahi AgroResearch Co., Ltd.
    • Shionogi Smile Heart Co., Ltd
    • UMN Pharma Inc.
    • Shionogi B.V.
UsernamePublicRestriction

Register